Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,511 | 8,103 | 12,977 | 18,358 | 21,938 |
| Marketable Securities | 16,502 | 19,951 | 20,286 | 20,000 | 19,365 |
| TOTAL | $25,248 | $29,921 | $35,292 | $39,471 | $43,341 |
| Non-Current Assets | |||||
| PPE Net | 47 | 49 | 50 | 50 | 52 |
| Other Non-Current Assets | 277 | 323 | 245 | 213 | 254 |
| TOTAL | $324 | $372 | $295 | $263 | $306 |
| Total Assets | $25,572 | $30,293 | $35,587 | $39,734 | $43,648 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,140 | 3,404 | 4,437 | 3,775 | 2,505 |
| TOTAL | $4,331 | $3,601 | $4,601 | $3,953 | $2,678 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 53 | 94 | 55 | 16 | 62 |
| TOTAL | $53 | $94 | $55 | $16 | $62 |
| Total Liabilities | $4,384 | $3,695 | $4,656 | $3,969 | $2,740 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,785 | 10,785 | 10,765 | 10,759 | 10,741 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -76,026 | -70,150 | -65,645 | -60,685 | -55,244 |
| Other shareholders' equity | 154 | -25 | -7 | 2 | -108 |
| TOTAL | $21,188 | $26,598 | $30,931 | $35,765 | $40,908 |
| Total Liabilities And Equity | $25,572 | $30,293 | $35,587 | $39,734 | $43,648 |